Correlation Between Ziff Davis and Cyclo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ziff Davis and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ziff Davis and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ziff Davis and Cyclo Therapeutics, you can compare the effects of market volatilities on Ziff Davis and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ziff Davis with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ziff Davis and Cyclo Therapeutics.

Diversification Opportunities for Ziff Davis and Cyclo Therapeutics

-0.18

Correlation Coefficient

Ziff Davis  Cyclo Therapeutics

Good diversification

The 3 months correlation between Ziff and Cyclo is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Ziff Davis and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Ziff Davis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ziff Davis are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Ziff Davis i.e., Ziff Davis and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between Ziff Davis and Cyclo Therapeutics

Allowing for the 90-day total investment horizon Ziff Davis is expected to under-perform the Cyclo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ziff Davis is 6.71 times less risky than Cyclo Therapeutics. The stock trades about -0.25 of its potential returns per unit of risk. The Cyclo Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  13.00  in Cyclo Therapeutics on December 17, 2024 and sell it today you would earn a total of  2.00  from holding Cyclo Therapeutics or generate 15.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ziff Davis  vs.  Cyclo Therapeutics

Ziff Davis

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ziff Davis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Cyclo Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical indicators, Cyclo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ziff Davis and Cyclo Therapeutics

The main advantage of trading using opposite Ziff Davis and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ziff Davis position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.

The idea behind Ziff Davis and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.